Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: dm

Treatments: Drug: Vildagliptin; Drug: vildagliptin\metformin

Study type: Interventional

Funder types: Other

Identifiers

NCT03925701

diabetes mellitus tanta

Details and patient eligibility

About

Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.

Full description

Clinical study evaluating vildagliptin versus vildagliptin/metformin on nonalcoholic fatty liver disease with DM.

Enrollment: 120 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• NAFLD and type 2 DM

Exclusion criteria

• Viral hepatitis.
• Child score more than 6.
• renal impairment.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

120 participants in 2 patient groups

vildagliptin

Experimental group

Description:

vildagliptin 50 mg twice daily

Treatment:

Drug: Vildagliptin

vildagliptin\metformin

Active Comparator group

Description:

vildagliptin\\metformin twice daily

Treatment:

Drug: vildagliptin\metformin